TCR2 Therapeutics' Seed VC Round

TCR2 Therapeutics raised a round of funding on December 31, 2015. Investors include MPM Capital.

TCR2 Therapeutics, founded by MPM Capital, is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy. The company's vast expertise in T cell engagement and a deep u…

Articles about TCR2 Therapeutics' Seed VC Round: